XRAY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the provided data, DENTSPLY SIRONA Inc (XRAY) does not present a strong buying opportunity for a beginner investor with a long-term strategy. The stock lacks positive momentum, has mixed analyst ratings with downward price target revisions, and no significant positive catalysts or trading signals. Holding off on investment is recommended until more favorable conditions emerge.
The MACD is positive and expanding, indicating mild bullish momentum. RSI is neutral at 56.079, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong directional trend. Key support is at 9.84, and resistance is at 10.75. The stock's technical indicators do not strongly favor a buy at this time.
NULL identified. No recent news or significant insider or hedge fund activity. The stock has a mild pre-market and post-market gain, but it is not substantial enough to act as a catalyst.
Analyst ratings are predominantly negative, with multiple firms lowering price targets. Citi initiated coverage with a Sell rating and highlighted concerns about macroeconomic pressures and competition in the dental sector. Historical stock trends indicate a likelihood of negative performance in the short term (-3.31% in the next week, -5.81% in the next month).
No financial data available for analysis. The latest quarter season is not specified.
Analyst sentiment is mixed to negative. Barclays has an Underweight rating with a price target of $9. UBS maintains a Buy rating but lowered the price target to $17. Citi initiated coverage with a Sell rating and a $10 price target, citing macroeconomic pressures and competition. Evercore ISI lowered its price target to $13 from $15, maintaining an In Line rating.
